Last month, COVID-19 Working Group headed by Dr N K Arora had also recommended to the health ministry inclusion of Covovax on the CoWIN por...

The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9,...

The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adul...

"The Subject Expert Committee of the CDSCO on Wednesday deliberated on the issue and had recommended for market authorisation of Covid jab ...

Prakash Kumar Singh, director (government and regulatory affairs) at Serum Institute of India (SII) had recently written a letter to Drugs ...

Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII), had written a letter to the the D...

Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for the heterologous bo...

In an application, SII Director for Government and Regulatory Affairs Prakash Kumar Singh has sought permission to conduct the Phase-3, obs...

India's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12-17 ...

Poonawalla, in an exclusive interview with ANI, said, "We have a stockpile of 200 million doses of Covishield...We've already exported 40 m...

Covovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing auth...

India's drug regulator had granted restricted emergency use authorisation to Covovax for the 12 to 17 years age group subject to certain co...

The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation had on Friday recommended giving permission for...

Covovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing auth...

India's drug regulator had on December 28 granted emergency use authorisation (EUA) to Covovax. However, with the government not planning t...

The government had placed an order for Corbevax even before it received emergency use authorisation (EUA). It paid ₹1,500 crore in advance ...

India is gearing up to tackle a possible third wave of the coronavirus pandemic as the Omicron variant of the virus, which is said to be mu...